7081 PHARMA | Malaysia
PHARMANIAGA BHD
RM 5.05 on: 2021-01-19
-2.32% Past 1-day return
-4.17% Past 5-day return
Price/Valuation Analysis
Current Price Status
-
Stock is Shooting to the Moon
Stock is over-priced on the upper end by the market with the expectation of annual earning growth at 374.85% to match current price.
Stock in booming mode can be traded very volatile, price can swing largely day-to-day. While having big upside potential, the downside risk can be huge if the stock is not meeting the market expectation. -
Company is not in Profit
Fair Value
- PHARMA current price is 274.07% above OneDelta estimated fair value.
-
The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.
Relative Price Performance
-
Underperformed
PHARMA past 5-day return lagged behind the Pharmaceuticals industry average return by 6.89% -
Below 30-Day Average
Current price RM5.05 is below 30-day average RM5.12 by 1.4%
| Return (%) | PHARMA | Pharmaceuticals |
|---|---|---|
| 1-Day | -2.32% | +0.09% |
| 5-Day | -4.17% | +2.72% |
| 30-Day | -4.72% | +1.58% |
Bank Analyst Price Targets
HOLD
RM 5.70
SELL
RM 1.80
HOLD
RM 4.74
Revenue & Earning Growth Analysis
-
Recent Weak Revenue Growth
PHARMA posted a weaker revenue growth in the recent quarter than normal average.
-
Unstable Profit Growth
PHARMA has been experiencing substantial ups and downs on profit growth.
Past Quarter Reports
| Quarter Date | Revenue (RM) | (%) | EPS (RM) | (%) |
|---|---|---|---|---|
| 2020-09-30 | 624,804k | -3% | 0.0055 | -86% |
| 2020-06-30 | 645,763k | -21% | 0.0382 | -55% |
| 2020-03-31 | 819,921k | +15% | 0.0857 | 0% |
| 2019-12-31 | 715,683k | -0% | -0.6845 | 0% |
| 2019-09-30 | 716,849k | +19% | 0.0018 | -95% |
Volume Trend Analysis
-
Recent Volume is Increasing
Surge in trading volume tends to bring more price volatility in near term.
-
PHARMA recent daily traded volume is 109.09% higher than past month average.
| Past 30-Day | Past 5-Day |
|---|---|
| 11k daily | 23k daily |
Financials
Price History Chart
Past 30-day Average Price: RM5.12
Stock Fundamental Factors
Fundamental factor characteristics help us understand and expect how the stock price will behave in short and long term.
Stock Thematic Baskets
Usually the more the stock is included in popular themes, the more opportunity for price-driven momentum and better liquidity.
Market News & Investor Opinions
Pharmaniaga in talks with MoH over Covid-19 vaccine purchase
RHB Research upgrades Duopharma to 'buy', raises target price to RM4
CGS-CIMB upgrades Pharmaniaga to 'hold', raises target price to RM5.41
RHB Research upgrades Duopharma to Buy with RM4 target price
Pharmaniaga to produce Sinovac Covid-19 vaccines
Pharmaniaga rises 5% on partnership with Sinovac
Pharmaniaga to manufacture Sinovac Covid-19 vaccine starting March
Duopharma gets one-year extension for supply of human insulin products
Duopharma Biotech gets deal extension
Pharmaniaga set to distribute vaccines efficiently, prioritising safety aspects
Stock Company Profile
PHARMANIAGA BHD
Pharmaniaga Bhd. is an investment holding company. It engages in the research & development, manufacturing of generic pharmaceutical products, sales & marketing as well as logistics and distribution of pharmaceutical products & medical equipment. The firm operates through the following segments: Logistics and Distribution, Manufacturing, and Indonesia. The Logistics and Distribution segment engages in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia. The Manufacturing segment manufactures pharmaceutical products in Malaysia. The Indonesia segment manufactures and distributes pharmaceutical and medical products in Indonesia. The company was founded on August 21, 1998 and is headquartered in Shah Alam, Malaysia.